Stem-Immunity Hubs Are Associated with Immunotherapy Response in Lung Cancer

Skip Nav Destination

April 9, 2024

Major Finding: Stem-immunity hubs are associated with response to immunotherapy in non–small cell lung cancer.

Concept: These CXCL10/CXCL11-expressing immunity hubs are enriched for TCF7⁺CD8⁺ T cells and CCL19.

Impact: This immune cell spatial organization could be leveraged to predict or enhance immunotherapy response.

DOI:https://doi.org/10.1158/2159-8290.CD-RW2024-053

Article Type: Research Watch

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Stem-Immunity Hubs Are Associated with Immunotherapy Response in Lung Cancer Available to Purchase